Effect of Vitamin D Deficiency on the Frequency and Severity of Spinal Anesthesia-Induced Hypotension in Pregnant Women Undergoing Cesarean Section
1 other identifier
observational
140
1 country
1
Brief Summary
Spinal anesthesia-induced hypotension remains a common and significant complication during cesarean sections, posing risks for both mother and fetus. Vitamin D deficiency, frequently observed in pregnant women, is associated with altered vascular function and potential hemodynamic instability. This prospective observational study aims to investigate whether vitamin D deficiency is associated with an increased incidence and severity of spinal anesthesia-induced hypotension in pregnant women undergoing elective cesarean delivery. Vitamin D levels will be measured preoperatively, and intraoperative hemodynamic parameters will be closely monitored. The findings could contribute to improved management strategies for pregnant patients at risk of severe hypotension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 30, 2025
CompletedFirst Posted
Study publicly available on registry
July 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedJanuary 6, 2026
January 1, 2026
10 months
June 30, 2025
January 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of Hypotension After Spinal Anesthesia
Hypotension is defined as a ≥20% decrease in systolic blood pressure from baseline or an absolute systolic value \<90 mmHg. The presence or absence of hypotension will be recorded.
ntraoperative (0-30 minutes after spinal anesthesia)
Secondary Outcomes (2)
Total Vasopressor Dose Administered
Intraoperative (0-30 minutes after spinal anesthesia)
Total Crystalloid Volume Administered
Intraoperative (0-30 minutes after spinal anesthesia)
Study Arms (2)
Vitamin D Deficient Group
Pregnant women with serum 25-hydroxyvitamin D levels below the defined deficiency threshold
Vitamin D Sufficient Grup
Pregnant women with normal or sufficient vitamin D levels
Interventions
Continuous intraoperative monitoring of systolic blood pressure and heart rate following spinal anesthesia. Vasopressor usage and total fluid administration will be recorded.
Eligibility Criteria
Pregnant women aged 18 years and older who are scheduled for elective cesarean section under spinal anesthesia at a tertiary care university hospital. All participants will be clinically stable and provide informed consent prior to enrollment. The study population will be stratified based on serum vitamin D levels into deficient and sufficient groups for analysis of hypotension outcomes.
You may qualify if:
- Pregnant women aged 18 years or older
- Scheduled for elective cesarean delivery under spinal anesthesia
- Able and willing to provide written informed consent
You may not qualify if:
- Emergency cesarean sections
- History of significant cardiovascular disease (e.g., arrhythmia, heart failure)
- Known neurological disorders affecting autonomic function
- Current vitamin D supplementation within the past 30 days
- Inability to undergo blood sampling or provide valid hemodynamic data
- Contraindication to spinal anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duzce Universitylead
Study Sites (1)
Duzce University Faculty of Medicine, Department of Anesthesiology and Reanimation
Düzce, Merkez, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2025
First Posted
July 9, 2025
Study Start
March 1, 2025
Primary Completion
December 30, 2025
Study Completion
December 30, 2025
Last Updated
January 6, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
The study involves sensitive clinical data from pregnant women. Individual participant data will not be shared publicly due to privacy concerns.